Moderna’s stock surges after better-than-expected quarterly results

May 2, 2024 · Moderna’s stock jumped on Thursday as the company reported a narrower-than-expected first-quarter loss and looks to launch its second product in the U.S. later this year.

7%
OFF

Moderna's Stock Pops After Surprise Quarterly Profit, Even As …

2 weeks from now

Feb 22, 2024 · Moderna Inc. shares (MRNA) jumped more than 7% premarket on Thursday after the company reported a surprise fourth-quarter profit, even as its COVID product sales …

morningstar.com

$13
OFF

Moderna Shares Surge After Vaccine Maker Posts Unexpected Third …

2 weeks from now

Nov 7, 2024 · Moderna also unveiled net profit of $13 million, or $0.03 a share, compared to a loss of $3.6 billion a year ago and above expectations for a loss of $753 million, according to …

yahoo.com

$13
OFF

Moderna Reports Surprise Profit On Higher-than-expected COVID …

2 weeks from now

Nov 7, 2024 · Moderna posted a profit of $13 million, or 3 cents a share, for the quarter, compared to a loss of $3.6 billion a year ago. Analysts had expected a loss of $753 million, or $1.90 a …

yahoo.com

14%
OFF

Moderna Stock Surges 14% After Covid Vaccine-Maker Surprises …

2 weeks from now

Feb 22, 2024 · Moderna expected the sales drop-off in the fourth quarter and 2023. Vaccination rates were 20% to 30% higher in the fall and winter of 2022 than the same period of 2023, …

investors.com

6%
OFF

Moderna Adds 6% On Better-than-expected Quarterly Results

2 weeks from now

Feb 22, 2024 · Moderna shares are up more than 6 percent in pre-market. The stock had closed at $87.59, up 0.69 percent on Wednesday. It has traded in the range of $62.55 - $163.24 in …

businessinsider.com

$167
OFF

Moderna Shares Jump After Better-Than-Expected Sales - The …

2 weeks from now

May 2, 2024 · First-quarter sales of Moderna’s Covid-19 vaccine plunged to $167 million from $1.8 billion a year earlier, as demand for the shots plummeted, but still came in higher than …

wsj.com

16%
OFF

Moderna Stock Surges After Covid Vaccine Sales Obliterate …

2 weeks from now

Aug 3, 2022 · Moderna stock soared 16% to close at 186.49 on today's stock market. Moderna Stock: Sales Unexpected Rise Overall, Moderna earned $5.24 per share on $4.75 billion in …

investors.com

9%
OFF

Moderna's Stock Surges After Better-than-expected Quarterly …

2 weeks from now

May 2, 2024 · Moderna Inc.'s stock jumped 9% Thursday as the company reported a narrower-than-expected first-quarter loss and looks toward launching its second product in the U.S. later …

morningstar.com

$19
OFF

Moderna Surprises The Street By Predicting A Bigger-Than …

2 weeks from now

2 days ago · The company will detail its fourth-quarter results on Feb. 14. Moderna is a couple years removed from pulling in more than $19 billion in sales annually after initial vaccination …

usnews.com

17%
OFF

Moderna Stock Plummets 17% On 2025 Sales Guidance Slash

2 weeks from now

1 day ago · Management expects to close the year with cash, cash equivalents and investments of around $9.5 billion. Full details for the fourth quarter and full year 2024 will be provided on …

nasdaq.com

94%
OFF

Moderna Stock Has Lost 94% Of Its Value Over Four Years. Is It A …

2 weeks from now

1 day ago · Moderna stock took a beating in January after the company slashed its outlook for 2024 and 2025 and missed the mark in a CMV study. Shares hit another skid on Jan. 13 when …

investors.com

7%
OFF

Moderna (MRNA) Stock Jumps 11.7%: Will It Continue To Soar?

2 weeks from now

Jan 8, 2025 · This biotechnology company is expected to post quarterly loss of $3 per share in its upcoming report, which represents a year-over-year change of -645.5%. Revenues are …

yahoo.com

5%
OFF

Moderna’s Stock Jumps 5% Premarket After Narrower-than …

2 weeks from now

Aug 3, 2023 · Moderna Inc.’s stock MRNA rallied 5.5% in premarket trade Thursday, after the COVID vaccine market posted a narrower-than-expected second-quarter loss and revenue …

marketwatch.com

20%
OFF

Moderna's $1 Billion Revenue Forecast Cut Sends Stock

2 weeks from now

2 days ago · Shares of Moderna dropped more than 20% intraday to $33.44, more than erasing gains last week after the first bird-flu death was reported in the U.S. The stock has lost about …

investopedia.com

FAQs about Moderna’s stock surges after better-than-expected quarterly results Coupon?

Why did Moderna stock rise 7% Thursday?

Moderna shares shot up about 7% Thursday after reporting better-than-expected quarterly sales and signaling confidence in a sales pickup later this year. First-quarter sales of Moderna’s Covid-19 vaccine plunged to $167 million from $1.8 billion a year earlier, as demand for the shots plummeted, but still came in higher than analysts expected. ...

How much did Moderna make a year ago?

Moderna also unveiled net profit of $13 million, or $0.03 a share, compared to a loss of $3.6 billion a year ago and above expectations for a loss of $753 million, according to LSEG data cited by Reuters. Shares in Moderna surged in premarket US trading on Thursday. ...

How much will Moderna make next quarter?

Mock said during an investor call that Moderna expected between $200 million and $500 million in overall sales next quarter, assuming COVID vaccination rates are flat or down as much as 10% compared to last year. ...

Why did Moderna's quarterly results not meet analyst expectations?

Moderna reported quarterly results well short of analyst expectations last month as demand for its Covid-19 vaccine wanes. Already a WSJ subscriber? Sign in Register to access limited number of articles. Subscribe to get unlimited access to articles. ...

How did Moderna perform in early trading?

Shares of the Cambridge, Massachusetts-based company were up nearly 5% to $54.22 in early trading. Moderna posted a profit of $13 million, or 3 cents a share, for the quarter, compared to a loss of $3.6 billion a year ago. Analysts had expected a loss of $753 million, or $1.90 a share, according to LSEG data. ...

Is Moderna a good stock to buy?

Photo: joel saget/Agence France-Presse/Getty Images Moderna Inc.’s stock was higher but off its early highs Thursday, after the company’s third-quarter earnings showed an unexpected profit as well as revenue that beat estimates by a wide margin. ...